Plughitz Live Special Events (audio)

Trilogy Technologies' blood glucose and cholesterol device @ CES 2024

Informações:

Sinopsis

Non-invasive blood glucose monitoring is a new technology designed to simplify and enhance the convenience of monitoring blood glucose levels for individuals with diabetes. Trilogy Technologies, a company specializing in non-invasive medical devices, has developed a device that not only detects blood glucose levels but also measures uric acid and total cholesterol levels. This device provides a painless and convenient method for individuals with diabetes to monitor their blood glucose levels, a significant improvement over traditional methods that require finger pricking.Non-invasive blood glucose monitoringThis device is considered a game changer in the market as it eliminates the need for traditional methods such as drawing blood and testing it in certified labs. Pre-clinical trials have been conducted on the device, and it has demonstrated an accuracy rate of 93.49% compared to the golden standard.The device is compact and user-friendly, requiring no needles or jabs, thus offering a painless experience. To